BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference
POMPANO BEACH, Fla., June 10, 2026 — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the Planet MicroCap Las Vegas 2026 Conference. BioStem is scheduled to present on Wednesday, June 17, 2026, at […]
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
Broomfield, CO, June 10, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through its Nociscan® platform to help physicians identify the location of chronic low back pain and support improved treatment […]
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
The new independent directors strengthen the Company’s board as seasoned executives bring deep expertise in life sciences commercialization, healthcare administration, and investment management PR Audio: POMPANO BEACH, Fla., June 9, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the […]
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion’s AI-driven platform for chronic low back pain. Program aims to follow successful reimbursement wins in the UK that are translating into sustained scan volume growth in step with reduced market access barriers PR Audio: Broomfield, CO, June 09, 2026 – PRISM MediaWire (Press Release Service […]
Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation
PR Audio: Broomfield, CO, June 3, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through its Nociscan® platform to help physicians identify the location of chronic low back pain […]
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study
PR Audio: BROOMFIELD, Colo., June 1, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced […]
PRISM MarketView Spotlights Seven Public Companies Advancing Mental Health Innovation During National Mental Health Awareness Month
Growing investor interest in brain health, workplace resilience, and next-generation mental health treatments PR Audio: NEW YORK, May 26, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – PRISM MarketView, the financial media platform serving active retail and self-directed investors, today highlighted seven public companies developing therapies, devices, and digital platforms aimed at […]
American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on June 24, 2026
SAN FRANCISCO, CA, May 22, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, today announced that its Annual Meeting of Shareholders will be held on June 24, 2026, […]
BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor
Strengthening balance sheet on path to Nasdaq uplisting POMPANO BEACH, Fla., May 22, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced it has entered into a securities […]
BioStem Technologies Reports First Quarter 2026 Financial Results
POMPANO BEACH, Fla., May 14, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported financial results for the first quarter ended March 31, 2026. Recent Financial and Business Highlights “The […]